Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pacira Pharmaceuticals buy Jefferies Financial Group Inc.

Pacira Pharmaceuticals
Start price
€12.60
24.09.24 / 50%
Target price
€16.13
24.09.25
Performance (%)
73.02%
End price
€21.80
25.09.25
Summary
This prediction ended on 25.09.25 with a price of €21.80. With a performance of 73.02% the BUY prediction by Jefferies_Financial_ was a big success. Jefferies_Financial_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Pacira Pharmaceuticals -6.604% -6.604% -5.714%
iShares Core DAX® 0.437% 5.897% 8.047%
iShares Nasdaq 100 1.057% 0.920% 28.466%
iShares Nikkei 225® 1.769% 1.228% 47.574%
iShares S&P 500 0.368% 1.920% 23.200%

Comments by Jefferies_Financial_ for this prediction

In the thread Pacira Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 73.02%
Target price 16.126
Change
Ends at 24.09.25

Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target raised by analysts at Jefferies Financial Group Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat

Jefferies Financial Group Inc. 
0
Report Share
24.09.24
In the thread Trading Pacira Pharmaceuticals
Prediction Buy
Perf. (%) 73.02%
Target price 16.126
Change
Ends at 24.09.25

Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten

Jefferies Financial Group Inc. 
0
Report Share
25.09.25